FRM
ITCI

Fox Run Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Fox Run Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-16,667
Closed -$1.39M – 1293
2024
Q4 		$1.39M Buy
+16,667
New +$1.37M 0.25% 72
2024
Q3 		– Sell
-18,575
Closed -$1.27M – 1169
2024
Q2 		$1.27M Buy
+18,575
New +$1.29M 0.24% 111
2024
Q1 		– Sell
-3,289
Closed -$236K – 1119
2023
Q4 		$236K Buy
+3,289
New +$189K 0.06% 584
2022
Q4 		– Sell
-8,357
Closed -$389K – 936
2022
Q3 		$389K Sell
8,357
-359
-4% -$18.8K 0.15% 261
2022
Q2 		$498K Buy
+8,716
New +$494K 0.25% 120
2020
Q4 		– Sell
-10,882
Closed -$279K – 303
2020
Q3 		$279K Buy
+10,882
New +$248K 0.7% 50
2018
Q4 		– Sell
-10,109
Closed -$219K – 780
2018
Q3 		$219K Sell
10,109
-20,053
-66% -$419K 0.1% 455
2018
Q2 		$533K Buy
+30,162
New +$612K 0.17% 217
2018
Q1 		– Sell
-26,625
Closed -$386K – 967
2017
Q4 		$386K Buy
26,625
+1,925
+8% +$29.7K 0.11% 374
2017
Q3 		$390K Buy
+24,700
New +$362K 0.11% 387
2017
Q1 		– Sell
-15,300
Closed -$231K – 780
2016
Q4 		$231K Buy
+15,300
New +$216K 0.12% 390
2016
Q3 		– Sell
-8,200
Closed -$318K – 728
2016
Q2 		$318K Buy
+8,200
New +$295K 0.15% 268

Other funds holding ITCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Fox Run Management's ITCI Position: Q1 2025 in Review

Fox Run Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2025, closing a stake of 16,667 shares — an estimated $1.39M sold.

Fox Run Management first reported a position in ITCI in Q2 2016 and held it in 12 quarters. The position peaked at $1.39M in Q4 2024. 395 funds tracked by Wall St. Rank hold ITCI as of Q1 2025.

  • Fox Run Management reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2025 after selling out during the quarter.
  • Fox Run Management sold 16,667 Intra-Cellular Therapies Inc. shares in Q1 2025, an estimated $1.39M.
  • Fox Run Management first reported a position in Intra-Cellular Therapies Inc. in Q2 2016 and held it in 12 quarters.
  • Fox Run Management's Intra-Cellular Therapies Inc. position peaked at $1.39M in Q4 2024.
  • 395 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2025.

Based on Fox Run Management's 13F filing for Q1 2025, filed 13 May 2025.